HIGHLIGHTS
- who: Chaonan Wang et al. from the Changchun University of Chinese Medicine, Changchun, China have published the paper: Studies on the Antiliver Injury of Effective Parts from Saururus chinensis by Rats and Mice Model In Vivo, in the Journal: Evidence-Based Complementary and Alternative Medicine 400 of 26/04/2022
- what: The aim of this study was to evaluate the pharmacodynamics of the effective parts from Saururus chinensis (EPS) in vivo.
- how: The pharmacodynamics results showed that the rats` oral administration of EPS can significantly inhibit the formation of liver fibrosis in rats . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.